Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
复制标题
DOI:
10.1016/j.jmb.2011.04.013
复制
发表时间:
2011-07-29
影响因子:
5.6
通讯作者:
Prabhu KS
中科院分区:
文献类型:
--
作者:
Narayan V;Ravindra KC;Chiaro C;Cary D;Aggarwal BB;Henderson AJ;Prabhu KS
Current drugs used for anti-retroviral therapy against HIV have a narrow spectrum of activity, and more often have associated toxicities and severe side effects in addition to developing resistance. Thus, there is a need to develop new therapeutic strategies against HIV/AIDS to complement the already existing ones. Surprisingly, Tat, an early virus encoded protein required for the efficient transcription of the HIV genome, has not been developed as a target for small molecular therapeutics. We have previously described the ability of an endogenous Michael acceptor electrophile (MAE), 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), to inhibit Tat-dependent transcription, by targeting its cysteine (Cys) rich domain. In an effort to identify other MAEs possessing inhibitory activity against HIV-1 Tat, we tested a collection of plant-derived compounds with electrophilic properties, including curcumin, rosmarinic acid, and gambogic acid, for their ability to inhibit Tat. Celastrol (Cel), a triterpenoid MAE isolated from T. wilfordii, exhibited the highest inhibitory activity against Tat. Using biochemical techniques, we demonstrate that Cel by covalently modifying the cysteine thiols inhibits Tat transactivation function. Using circular dichroism (CD) spectroscopy, we show that alklylation of Tat brought about a change in the secondary structure of Tat, which inhibited the transcription elongation of the HIV proviral genome by effecting mechanisms other than Tat-TAR interaction. Our results demonstrate the underlying mechanism of anti-retroviral activity of the plant-derived MAEs, and suggest that Cel could serve as a lead compound to develop novel anti-viral therapeutics.
登录
查看更多内容
影响因子:
3.3
作者:
Agbottah, Emmanuel;Deng, Longwen;Dannenberg, Luke O.;Pumfery, Anne;Kashanchi, Fatah
通讯作者:
Kashanchi, Fatah
影响因子:
11
作者:
Emiliani, Stephane;Coudronniere, Nolwenn;Devaux, Christian
通讯作者:
Devaux, Christian
影响因子:
64.8
作者:
KAO, SY;CALMAN, AF;PETERLIN, BM
通讯作者:
PETERLIN, BM
影响因子:
1.6
作者:
Kirsch, T;Boehm, M;Rosch, P
通讯作者:
Rosch, P
DOI:
10.1101/sqb.1998.63.371
发表时间:
1998-01-01
期刊:
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
影响因子:
--
作者:
Garber, ME;Wei, P;Jones, KA
通讯作者:
Jones, KA